Who
Michael Cooper Pearce
Director
Company insider
Files Form 4 as: Director, Journey Medical; President and CEO, Pernix Therapeutics Holdings.
In numbers
- Trades disclosed
- 78
- Buys
- 0
- Sells
- 23
- Bought
- $0
- Sold
- $1.5M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 14 Dec 2007
- Last trade
- 25 Jun 2026
- Last filed
- 26 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jun 2026filed 26 Jun 2026 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 25 Jun 2026filed 26 Jun 2026 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 5 Aug 2025filed 7 Aug 2025 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 25 Jun 2025filed 7 Jul 2025 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code A | —7,173 at $0.00 | filing |
| 19 Jul 2024filed 23 Jul 2024 | DERM Journey MedicalPharmaceuticals | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 10 May 2013filed 13 May 2013 | Pernix Therapeutics Holdingsoption or derivative | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 10 May 2013filed 13 May 2013 | Pernix Therapeutics Holdings | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 28 Nov 2012filed 29 Nov 2012 | Pernix Therapeutics Holdingsoption or derivative | SEC FORM 4 Code M | —8,843 at $0.00 | filing |
| 28 Nov 2012filed 29 Nov 2012 | Pernix Therapeutics Holdings | SEC FORM 4 Code M | $37K8,843 at $4.20 | filing |
| 28 Nov 2012filed 29 Nov 2012 | Pernix Therapeutics Holdings | SEC FORM 4 Sold | $62K8,843 at $7.00 | filing |
| 27 Nov 2012filed 29 Nov 2012 | Pernix Therapeutics Holdingsoption or derivative | SEC FORM 4 Code M | —1,100 at $0.00 | filing |
| 27 Nov 2012filed 29 Nov 2012 | Pernix Therapeutics Holdings | SEC FORM 4 Code M | $4,6201,100 at $4.20 | filing |
| 27 Nov 2012filed 29 Nov 2012 | Pernix Therapeutics Holdings | SEC FORM 4 Sold | $7,7001,100 at $7.00 | filing |
| 26 Nov 2012filed 26 Nov 2012 | Pernix Therapeutics Holdingsoption or derivative | SEC FORM 4 Code M | —25,917 at $0.00 | filing |
| 26 Nov 2012filed 26 Nov 2012 | Pernix Therapeutics Holdings | SEC FORM 4 Code M | $109K25,917 at $4.20 | filing |
| 26 Nov 2012filed 26 Nov 2012 | Pernix Therapeutics Holdings | SEC FORM 4 Sold | $186K25,917 at $7.18 | filing |
| 23 Nov 2012filed 26 Nov 2012 | Pernix Therapeutics Holdingsoption or derivative | SEC FORM 4 Code M | —8,800 at $0.00 | filing |
| 23 Nov 2012filed 26 Nov 2012 | Pernix Therapeutics Holdings | SEC FORM 4 Code M | $37K8,800 at $4.20 | filing |
| 23 Nov 2012filed 26 Nov 2012 | Pernix Therapeutics Holdings | SEC FORM 4 Sold | $65K8,800 at $7.41 | filing |
| 21 Nov 2012filed 23 Nov 2012 | Pernix Therapeutics Holdingsoption or derivative | SEC FORM 4 Code M | —3,440 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.